ORGO stock forecast
Our latest prediction for Organogenesis Holdings, Inc.'s stock price was made on the Sept. 13, 2019 when the stock price was at 6.01$.
In the short term (2weeks), ORGO's stock price should outperform the market by 3.14%. During that period the price should oscillate between -10.44% and +16.85%.
In the medium term (3months), ORGO's stock price should outperform the market by 3.55%. During that period the price should oscillate between -19.53% and +35.74%.Get email alerts
Create a solid portfolio with ORGO
About Organogenesis Holdings, Inc.
Organogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
At the moment the company generates 261M USD in revenues.
On its last earning announcement, the company reported a loss of -0.44$ per share.
The book value per share is 0.25$
Three months stock forecastSept. 13, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|